Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By https://abelhlce449515.blogscribble.com/36380918/tirzepatide-a-promising-new-treatment-for-obesity